Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer with Mediastinal Lymph Node Involvement

Thoracic Surgery Clinics

Volumn 18, Issue 4, 2008, Pages 403-415

  Tieu, Brandon H ^a   Sanborn, Rachel E ^b   Thomas Jr , Charles R ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ERLOTINIB; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; VANDETANIB; VINBLASTINE; VINDESINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG TOLERABILITY; ENDOSCOPIC ECHOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HEMOPTYSIS; HIGH RISK POPULATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LUNG ADENOCARCINOMA; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; MICROEMBOLISM; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMEMBRANOUS COLITIS; RADIATION DOSE FRACTIONATION; RESPIRATORY FAILURE; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SINGLE DRUG DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THORACOTOMY; THROMBOCYTOPENIA; TRANSBRONCHIAL ASPIRATION; TRANSTHORACIC ASPIRATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINUM; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY;

EID: 53649097712     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2008.07.004     Document Type: Review

References (47)

1. National Cancer Institute. Surveilance, epidemiologic, and end results public use data 2007. Available at:. http://seer.cancer.gov Accessed July 14, 2008
2. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
4. DeCamp Jr. M.M., Ashiku S., and Thurer R. The role of surgery in N2 non-small cell lung cancer. Clin Cancer Res 11 (2005) 5033s-5037s
5. Rami-Porta R., Ball D., Crowley J., et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 593-602
6. Rusch V.W., Crowley J., Giroux D.J., et al. The IASLC lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 603-612
7. Postmus P.E., Brambilla E., Chansky K., et al. The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2 (2007) 686-693
8. Prenzel K.L., Mönig S.P., Sinning J.M., et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123 (2003) 463-467
9. Choi Y.S., Shim Y.M., Kim J., et al. Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 75 (2003) 364-366
10. Toloza E.M., Harpole L., and McCrory D.C. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 137S-146S
11. Birim O., Kappetein A.P., Stijnen T., et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 79 (2005) 375-382
12. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
13. Toloza E.M., Harpole L., Detterbeck F., et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 157S-166S
14. Meko J., and Rusch V.W. Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer. Semin Radiat Oncol 10 (2000) 324-332
15. Martini N., Kris M.G., Flehinger B.J., et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55 (1993) 1365-1373 [discussion: 1373-4]
16. Rosell R., Gómez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
17. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
18. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
19. Pass H.I., Pogrebniak H.W., Steinberg S.M., et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53 (1992) 992-998
20. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIA non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
21. Betticher D.C., Hsu Schmitz S.F., Tötsch M., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
22. De Marinis F., Nelli F., Migliorino M.R., et al. Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA (N2) nonsmall cell lung carcinoma: a Phase II multicenter study. Cancer 98 (2003) 1707-1715
23. van Meerbeeck J.P., Kramer G.W., van Schil P.E., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
24. Van Zandwijk N., Smit E.F., Kramer G.W., et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18 (2000) 2658-2664
25. O'Brien M.E., Splinter T., Smit E.F., et al. Carboplatin and paclitaxel (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958). Eur J Cancer 39 (2003) 1416-1422
26. Biesma B., Manegold C., Smit H.J., et al. Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer (EORTC 08984). Eur J Cancer 42 (2006) 1399-1406
27. Cappuzzo F., Selvaggi G., Gregorc V., et al. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study. Cancer 98 (2003) 128-134
28. Garrido P., González-Larriba J.L., Insa A., et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol 25 (2007) 4736-4742
29. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
30. Curran W.J., Scott C.B., Langer C.J., et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. [abstract]. Proc Am Soc Clin Oncol 22 (2003) 2499
31. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
32. Albain K.S., Swann R.S., Rusch V.W., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol 23 (2005) 7014 [abstract]
33. Uy K.L., Darling G., Xu W., et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg 134 (2007) 188-193
34. Katayama H., Ueoka H., Kiura K., et al. Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer 90 (2004) 979-984
35. Eberhardt W., Le Pechoux C., and Gauler T. Multicenter German/French phase II trial of induction chemotherapy (CTx) followed by hyperfractionated accelerated thoracic radiotherapy with CTx +/- surgery in locally advanced inoperable non-small cell lung cancer stage III patients: mature results of a novel induction CTx regimen. Lung Cancer 46 (2004) S40-S41 [abstract]
36. Bueno R., Richards W.G., Swanson S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
37. Barlési F., Doddoli C., Chetaille B., et al. Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2 (2003) 558-562
38. Doddoli C., Barlesi F., Trousse D., et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 130 (2005) 416-425
39. Allen A.M., Mentzer S.J., Yeap B.Y., et al. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. Cancer 112 (2008) 1106-1113
40. Sandler A.B., Gray R., Perry M.C., et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355 (2006) 2542-2550
41. Pirker R., Szczesna A., von Pawel J., et al. FLEX: a randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 26 (2008) 3 [abstract]
42. Sobrero A.F., Maurel J., Fehrenbacher L., et al. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. J Clin Oncol 26 (2008) 2311-2319
43. Vermorken J., Mesia R., Vega V., et al. Cetuximab extends survival of patients with recurrent or metastatic SCCHN when added to first line platinum based therapy-Results of a randomized phase III (Extreme) study. Proc Am Soc Clin Oncol 25 (2007) 6091 [abstract]
44. Shepherd F.A., Pereira J.R., Ciuleanu T., et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353 (2005) 123-132
45. Rizvi N.A., Rusch V., Zhao B., et al. Single agent bevacizumab and bevacizumab in combination with docetaxel and cisplatin as induction therapy for resectable IB-IIIA non-small cell lung cancer. Proc Am Soc Clin Oncol 25 (2007) 18045 [abstract]
46. Coate L.E., Gately K., Barr M., et al. Phase II pilot study of neoadjuvant cetuximab in combination with cisplatin and gemcitabine in patients with resectable IB-IIIA non small cell lung cancer. Proc Am Soc Clin Oncol 24 (2006) 17107 [abstract]
47. Available at:. www.clinicaltrials.gov